BUSINESSBLOOMBERG
Drugmaker Parabilis Raises $745 Million in US IPO, Placement
Drugmaker Parabilis raised $745 million through a US IPO and placement. The funding round includes both an initial public offering and a placement.
Mentioned
Related Signal
Adjacent reporting
- SpaceX Seeks $75 Billion in IPO at $135 Per Share: Reuters
- Applied Aerospace & Defense Said to Raise $650 Million in US IPO
- Turnkey raises $12.5 million in round backed by Circle Ventures and Sequoia Capital
- Seaport Therapeutics Said to Raise $255 Million in IPO
- Digital Bank Forbright Seeking to Raise $158 Million in US IPO
- Bridge Growth Raises $790 Million to Extend Hold on Solace